IVF is currently regarded as a successful new technology with the number of IVF children
currently well over 8 million worldwide. This has been achieved by an explosive plethora of …

Aim The purpose was to explore whether the 6 weeks of growth hormone (GH) pretreatment
could increase the live birth rate of poor ovarian responders (POR). Methods This self …

Treatment of sub-fertile women aged≥ 40 years old (advanced maternal age (AMA)) is
challenging. Co-treatment with growth hormone (GH) is suggested to improve reproductive …

Background: The efficiency of in vitro fertilization is improved by growth hormone (GH)
during ovarian stimulation. Additionally, patients with diabetes experience impaired insulin …

Objective The efficacy of growth hormone (GH) co-treatment within a GnRH agonist long
regimen, in women with a normal ovarian response to controlled ovarian hyperstimulation …

Aims: This study aims to assess if growth hormone (GH) supplementation in POR patients
improves oocyte yield and PR in IVF-intracytoplasmic sperm injection (ICSI) cycles. Settings …

Objective To determine efficacy of gonadotropin (Gn) co-treated with growth hormone (GH)
on poor ovarian response (POR) patients undergoing in vitro fertilization/intracytoplasmic …

Most studies published so far suggest that the administration of growth hormone (GH) during
ovarian stimulation improves in vitro fertilization (IVF) outcomes, especially in older women …

Purpose Growth hormone (GH) supplementation in association with in vitro fertilization (IVF)
is worldwide again increasing, even though study outcomes have been discrepant. Since …

To estimate the efficacy of growth hormone (GH) co-treatment within an antagonist protocol
in IVF/ICSI cycles in poor responders. A prospective observational study involving 50 …